This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Gregor Frizzell
Gregor Frizzell
London +44 20 7067 2055 Download V-card

Gregor Frizzell is a partner in the firm's London corporate group.  Mr. Frizzell's practice focuses on cross-border mergers and acquisitions, venture capital transactions, securities and finance, joint ventures and collaborations, and general corporate and commercial advice.  He has been recommended by Legal 500 UK 2008 for his expertise in the M&A field.

  • Represented an investor in relation to the acquisition of oil and gas blocks in Africa.
  • Represented ICICI Bank Limited and Standard Chartered Bank, as joint lead arrangers, on an aggregate of US$925m in project financing supporting two Reliance Group infrastructure companies.
  • Represented Cenkos Securities PLC in relation to Tanfield Group PLC’s £115m placing of ordinary shares on AIM.
  • Represented borrower in relation to a $25m junior working capital facility.
  • Represented Thomson Reuters on English law aspects of the sale of its Medical Education business to ABRY Partners.
  • Represented SR One Limited, a venture capital fund, the lead investor in the Series C funding round for Addex Pharmaceuticals SA, a Swiss biotech company.
  • Represented Vantage Point Venture Partners on its Series A investment in Solar Century Holdings Limited.
  • Represented Giorgio Armani S.p.A. in relation to a cross-border acquisition and joint venture and on related licensing and franchising arrangements.
  • Represented QUALCOMM Inc. on its acquisitions of two UK venture-backed 3G-related software companies.
  • Represented a UK-listed private equity fund of funds on its recent share redemption.
  • Represented an early stage English biotech company on its Series B venture funding round.
  • Represented the majority shareholders of a UK venture-backed software company on the trade sale of the company to a US-listed buyer.
  • Represented the founder and director of a UK software company in connection with the Series A venture funding round of his company.
  • Represented a US-listed vaccines company on the spin-out of one of its medical device businesses to a venture-backed UK new company.
  • Legal 500 UK, M&A Premium Deals (2015-2016)
  • Legal 500 UK, Venture Capital (2015-2016)
  • Super Lawyers - London Rising Stars, Mergers & Acquisitions (2013)